Interventional therapies for malignant pleural effusions: The present and the future

    Research output: Contribution to journalReview article

    32 Citations (Scopus)

    Abstract

    The approach to management of malignant pleural effusions (MPE) has changed over the past few decades. The key goals of MPE management are to relieve patient symptoms using the least invasive means and in the most cost-effective manner. There is now a realization that patient-reported outcome measures should be the primary goal of MPE treatment, and this now is the focus in most clinical trials. Efforts to minimize patient morbidity are complemented by development of less invasive treatments that have mostly replaced the more aggressive surgical approaches of the past. Therapeutic thoracentesis is simple, effective and generally safe, although its benefits may only be temporary. Pleurodesis is the conventional and for a long time the only definitive therapy available. However, the efficacy and safety of talc pleurodesis has been challenged. Indwelling pleural catheter (IPC) drainage is increasingly accepted worldwide and represents a new concept to improve symptoms without necessarily generating pleural symphysis. Recent studies support the effectiveness of IPC treatment and provide reassurance regarding its safety. An unprecedented number of clinical trials are now underway to improve various aspects of MPE care. However, choosing an optimal intervention for MPE in an individual patient remains a challenge due to our limited understanding of the underlying pathophysiology of breathlessness in MPE and a lack of predictors of survival and pleurodesis outcome. This review provides an overview of common pleural interventional procedures used for MPE management, controversies and limitations of current practice, and areas of research most needed to improve practice in future. © 2014 Asian Pacific Society of Respirology.
    Original languageEnglish
    Pages (from-to)809-822
    Number of pages14
    JournalRespirology
    Volume19
    Issue number6
    Early online date19 Jun 2014
    DOIs
    Publication statusPublished - Aug 2014

    Fingerprint

    Malignant Pleural Effusion
    Pleurodesis
    Indwelling Catheters
    Therapeutics
    Clinical Trials
    Talc
    Safety
    Dyspnea
    Drainage
    Morbidity
    Costs and Cost Analysis
    Survival
    Research

    Cite this

    @article{3906fdb149914661a6d0ddea2584077a,
    title = "Interventional therapies for malignant pleural effusions: The present and the future",
    abstract = "The approach to management of malignant pleural effusions (MPE) has changed over the past few decades. The key goals of MPE management are to relieve patient symptoms using the least invasive means and in the most cost-effective manner. There is now a realization that patient-reported outcome measures should be the primary goal of MPE treatment, and this now is the focus in most clinical trials. Efforts to minimize patient morbidity are complemented by development of less invasive treatments that have mostly replaced the more aggressive surgical approaches of the past. Therapeutic thoracentesis is simple, effective and generally safe, although its benefits may only be temporary. Pleurodesis is the conventional and for a long time the only definitive therapy available. However, the efficacy and safety of talc pleurodesis has been challenged. Indwelling pleural catheter (IPC) drainage is increasingly accepted worldwide and represents a new concept to improve symptoms without necessarily generating pleural symphysis. Recent studies support the effectiveness of IPC treatment and provide reassurance regarding its safety. An unprecedented number of clinical trials are now underway to improve various aspects of MPE care. However, choosing an optimal intervention for MPE in an individual patient remains a challenge due to our limited understanding of the underlying pathophysiology of breathlessness in MPE and a lack of predictors of survival and pleurodesis outcome. This review provides an overview of common pleural interventional procedures used for MPE management, controversies and limitations of current practice, and areas of research most needed to improve practice in future. {\circledC} 2014 Asian Pacific Society of Respirology.",
    author = "Roslyn Francis and H.E. Davies and Rajesh Thomas and Gary Lee",
    year = "2014",
    month = "8",
    doi = "10.1111/resp.12328",
    language = "English",
    volume = "19",
    pages = "809--822",
    journal = "Asian Pacific Journal of Respirology",
    issn = "1323-7799",
    publisher = "John Wiley & Sons",
    number = "6",

    }

    Interventional therapies for malignant pleural effusions: The present and the future. / Francis, Roslyn; Davies, H.E.; Thomas, Rajesh; Lee, Gary.

    In: Respirology, Vol. 19, No. 6, 08.2014, p. 809-822.

    Research output: Contribution to journalReview article

    TY - JOUR

    T1 - Interventional therapies for malignant pleural effusions: The present and the future

    AU - Francis, Roslyn

    AU - Davies, H.E.

    AU - Thomas, Rajesh

    AU - Lee, Gary

    PY - 2014/8

    Y1 - 2014/8

    N2 - The approach to management of malignant pleural effusions (MPE) has changed over the past few decades. The key goals of MPE management are to relieve patient symptoms using the least invasive means and in the most cost-effective manner. There is now a realization that patient-reported outcome measures should be the primary goal of MPE treatment, and this now is the focus in most clinical trials. Efforts to minimize patient morbidity are complemented by development of less invasive treatments that have mostly replaced the more aggressive surgical approaches of the past. Therapeutic thoracentesis is simple, effective and generally safe, although its benefits may only be temporary. Pleurodesis is the conventional and for a long time the only definitive therapy available. However, the efficacy and safety of talc pleurodesis has been challenged. Indwelling pleural catheter (IPC) drainage is increasingly accepted worldwide and represents a new concept to improve symptoms without necessarily generating pleural symphysis. Recent studies support the effectiveness of IPC treatment and provide reassurance regarding its safety. An unprecedented number of clinical trials are now underway to improve various aspects of MPE care. However, choosing an optimal intervention for MPE in an individual patient remains a challenge due to our limited understanding of the underlying pathophysiology of breathlessness in MPE and a lack of predictors of survival and pleurodesis outcome. This review provides an overview of common pleural interventional procedures used for MPE management, controversies and limitations of current practice, and areas of research most needed to improve practice in future. © 2014 Asian Pacific Society of Respirology.

    AB - The approach to management of malignant pleural effusions (MPE) has changed over the past few decades. The key goals of MPE management are to relieve patient symptoms using the least invasive means and in the most cost-effective manner. There is now a realization that patient-reported outcome measures should be the primary goal of MPE treatment, and this now is the focus in most clinical trials. Efforts to minimize patient morbidity are complemented by development of less invasive treatments that have mostly replaced the more aggressive surgical approaches of the past. Therapeutic thoracentesis is simple, effective and generally safe, although its benefits may only be temporary. Pleurodesis is the conventional and for a long time the only definitive therapy available. However, the efficacy and safety of talc pleurodesis has been challenged. Indwelling pleural catheter (IPC) drainage is increasingly accepted worldwide and represents a new concept to improve symptoms without necessarily generating pleural symphysis. Recent studies support the effectiveness of IPC treatment and provide reassurance regarding its safety. An unprecedented number of clinical trials are now underway to improve various aspects of MPE care. However, choosing an optimal intervention for MPE in an individual patient remains a challenge due to our limited understanding of the underlying pathophysiology of breathlessness in MPE and a lack of predictors of survival and pleurodesis outcome. This review provides an overview of common pleural interventional procedures used for MPE management, controversies and limitations of current practice, and areas of research most needed to improve practice in future. © 2014 Asian Pacific Society of Respirology.

    U2 - 10.1111/resp.12328

    DO - 10.1111/resp.12328

    M3 - Review article

    VL - 19

    SP - 809

    EP - 822

    JO - Asian Pacific Journal of Respirology

    JF - Asian Pacific Journal of Respirology

    SN - 1323-7799

    IS - 6

    ER -